# GENETICA US: Biotechnology, Ho Chi Minh City, Vietnam

> GENETICA US: GENETICA® US is a biotechnology company based in San Francisco, founded in 2017. Based in Ho Chi Minh City, Vietnam. Founded 2017.

Source: https://millionrounds.com/startup/genetica-us (Millionrounds; every figure on the page links to its filing or article)

Vietnam · [Biotechnology startup](https://millionrounds.com/companies)

# GENETICA US

GENETICA® US is a biotechnology company based in San Francisco, founded in 2017.

Funding reported Last round: Seed

Biotechnology Ho Chi Minh City, Vietnam

Company summary

- **Founded:** 2017 9 years old
- **Team:** 35 11 to 50 people
- **Funding reported:** 2.5M as listed, currency not stated
- **Last round:** Seed Mar 2021

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for GENETICA US has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About GENETICA US

GENETICA® US is a biotechnology company based in San Francisco, founded in 2017.

It specializes in AI-powered genetic testing services tailored for the Asian population, with a strong focus on Southeast Asia, particularly Vietnam and Singapore, while also expanding into the United States. The company aims to enhance personal development and promote healthy living through precision medicine and personalized preventative care. The company offers low-cost saliva-based gene tests that analyze hundreds of genes and nearly one million variants. Their services include personalized reports on fitness and diet, child development, critical illness prevention, health risk assessments, and lifestyle recommendations. GENETICA® US utilizes a proprietary gene decoding chip developed in collaboration with Illumina® and Thermo Fisher Scientific, ensuring that their technology is specifically designed for Asian populations. With operational hubs in Vietnam and a commitment to customer support, GENETICA® US is recognized as a leading player in the direct-to-consumer gene testing market in Southeast Asia.

## What company datasets say GENETICA US raised

Funding, as reported

Reported in all **2.5M** in the source's currency

Rounds **1**

Last round **Seed**

Last round size **2.5M**

Last round date **Mar 2021**

Investors listed **3**

## On 2 portfolio pages

Investors who name them

- [AiViet Venture](https://millionrounds.com/fund/aiviet-venture)
- [R2 Venture Partners](https://millionrounds.com/fund/r2-venture-partners)

Each firm lists GENETICA US on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

genetic report printing health care fitness scheme recommendations genetic analysis for education and health consumers development planning genetic report reading guide genetic health risk assessment proprietary gene decoding technology genetic testing privacy policy genetic testing for children health risk assessment genetic decoding chip for asians genetic potential analysis for children genetic testing for health and wellness information technology & services

Built with from their website

Google Tag Manager Google Cloud YouTube Google Workspace CloudFlare Viewport Meta Google Play webpack Facebook SDK Amazon S3

+8 more

Google Cloud Hosting Google Meet CloudFlare CDN React Mobile Friendly Open Graph Facebook Pixel Squarespace

- **Sector:** Biotechnology
- **Industry code:** NAICS 541714, 621511, SIC 8731
- **Region:** Thành phố Hồ Chí Minh
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/genetica-us)

## Is this your company?

Add your raise, your deck and your story, and put GENETICA US in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)
